Are There Any Therapeutic Approaches Targeting LRRK2?
Yes, several therapeutic strategies are being explored to target LRRK2. These include kinase inhibitors that aim to reduce the abnormal kinase activity caused by LRRK2 mutations. Researchers are also investigating gene therapy approaches to correct the defective gene. Though these treatments are still largely in experimental stages, they represent a promising avenue for future Parkinson's disease therapies.
